Published in Indian J Clin Biochem on December 01, 2015
The model for end-stage liver disease (MELD). Hepatology (2007) 4.81
A comparison of fibrosis progression in chronic liver diseases. J Hepatol (2003) 2.82
Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol (2011) 2.82
Alcohol: its health and social impact in India. Natl Med J India (2006) 2.65
Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests. Clin Chim Acta (2007) 2.10
IL-6-deficient mice are susceptible to ethanol-induced hepatic steatosis: IL-6 protects against ethanol-induced oxidative stress and mitochondrial permeability transition in the liver. Cell Mol Immunol (2004) 1.28
Carbohydrate deficient transferrin in abstaining patients with end-stage liver disease. Alcohol Clin Exp Res (2001) 1.05
Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease. Alcohol Clin Exp Res (2008) 0.96
Molecular basis and current treatment for alcoholic liver disease. Int J Environ Res Public Health (2010) 0.94
Biochemical markers of hepatic fibrosis. Clin Biochem (1991) 0.89
Serum procollagen type III peptide as a marker of hepatic fibrogenesis in alcoholic hepatitis. Gastroenterology (1986) 0.85
Effect of the inducer of interleukin-6 (ME3738) on rat liver treated with ethanol. Alcohol Clin Exp Res (2007) 0.85
Diagnostic characteristics of different carbohydrate-deficient transferrin methods in the detection of problem drinking: effects of liver disease and alcohol consumption. Alcohol Alcohol (2003) 0.81
Prenatal alcohol exposure affects galactosyltransferase activity and glycoconjugates in the Golgi apparatus of fetal rat hepatocytes. Hepatology (1997) 0.80
[Identification of elevated carbohydrate-deficient transferrin (CDT) serum level as transferrin (Tf)-D-variant by means of isoelectric focusing]. Z Gastroenterol (2004) 0.79
Serum type I collagen and N-terminal peptide of type III procollagen in patients with alcoholic liver disease: relationship to liver histology. Alcohol Clin Exp Res (1992) 0.79
[Does carbohydrate-deficient transferrin have diagnostic value in non-alcoholic fatty liver disease?]. Orv Hetil (2009) 0.78
[Pathogenetic importance of proinflammatory cytokines in the formation and progression of fibrosis in alcoholic hepatitis]. Eksp Klin Gastroenterol (2013) 0.78
[Serum interleukin-6 concentrations in patients with alcoholic liver disease]. Pol Merkur Lekarski (2004) 0.78